ES723 Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases 72 cores, replacing BS02031 US Biomax 231 |
ES723 |
Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases 72 cores, replacing BS02031 |
US Biomax |
|
231€ |
|
Pub |
BC04118 Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
BC04118 |
Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
ES962 Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
ES962 |
Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LC1006 Non small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases 100 cores, with stage and grade data, replacing LC1001 US Biomax 231 |
LC1006 |
Non small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases 100 cores, with stage and grade data, replacing LC1001 |
US Biomax |
|
231€ |
|
Pub |
LC808 Lung squamous cell carcinoma tissue array, with TNM, stage and grade, 80 cases 80 cores, replacing BS04011 US Biomax 231 |
LC808 |
Lung squamous cell carcinoma tissue array, with TNM, stage and grade, 80 cases 80 cores, replacing BS04011 |
US Biomax |
|
231€ |
|
Pub |
OR601a Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed US Biomax 258 |
OR601a |
Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BC34111 Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases 72 cores, replaced by HN811 US Biomax 160 |
BC34111 |
Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases 72 cores, replaced by HN811 |
US Biomax |
|
160€ |
|
Pub |
BR727 Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011 US Biomax 231 |
BR727 |
Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011 |
US Biomax |
|
231€ |
|
Pub |
BR728 Breast carcinoma tissue array, with stage and grade info, 24 cases 72 cores, replacing BC08015 US Biomax 231 |
BR728 |
Breast carcinoma tissue array, with stage and grade info, 24 cases 72 cores, replacing BC08015 |
US Biomax |
|
231€ |
|
Pub |
BS02041 Esophagus squamous cell carcinoma (grade III) tissue array, 23 cases 63 cores US Biomax 160 |
BS02041 |
Esophagus squamous cell carcinoma (grade III) tissue array, 23 cases 63 cores |
US Biomax |
|
160€ |
|
Pub |
CO242a Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed US Biomax 81 |
CO242a |
Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed |
US Biomax |
|
81€ |
|
Pub |
CO243a Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed US Biomax 105 |
CO243a |
Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
CO722 Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases 72 cores, replacing BC05021 US Biomax 231 |
CO722 |
Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases 72 cores, replacing BC05021 |
US Biomax |
|
231€ |
|
Pub |
CO723 Colon well differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05021 US Biomax 231 |
CO723 |
Colon well differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05021 |
US Biomax |
|
231€ |
|
Pub |
CO724 Colon moderately differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05031 US Biomax 278 |
CO724 |
Colon moderately differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05031 |
US Biomax |
|
278€ |
|
Pub |
CO725 Colon poorly differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05041 US Biomax 231 |
CO725 |
Colon poorly differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05041 |
US Biomax |
|
231€ |
|
Pub |
ES2001 Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases 200 cores US Biomax 516 |
ES2001 |
Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases 200 cores |
US Biomax |
|
516€ |
|
Pub |
ES244 Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
ES244 |
Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
ES722 Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases 72 cores, replacing BC02023 US Biomax 231 |
ES722 |
Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases 72 cores, replacing BC02023 |
US Biomax |
|
231€ |
|
Pub |
ES802 Esophageal squamous cell carcinoma tissue array, grade I III, 40 cases 80 cores, no overlaps with ES801 US Biomax 231 |
ES802 |
Esophageal squamous cell carcinoma tissue array, grade I III, 40 cases 80 cores, no overlaps with ES801 |
US Biomax |
|
231€ |
|
Pub |
FDA808a-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed US Biomax 267 |
FDA808a-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
LC2081 Multiple lung carcinoma (Non small cell lung carcinoma, NSCLC) and normal tissue form necroscopy tissue array, 70 cases 208 cores, with stage and grade information US Biomax 456 |
LC2081 |
Multiple lung carcinoma (Non small cell lung carcinoma, NSCLC) and normal tissue form necroscopy tissue array, 70 cases 208 cores, with stage and grade information |
US Biomax |
|
456€ |
|
Pub |
LC482 Non small cell lung carcinoma (NSCLC) tissue array, with 4 normal tissue control from autopsy, 24 cases 48 cores, with grade and stage status US Biomax 160 |
LC482 |
Non small cell lung carcinoma (NSCLC) tissue array, with 4 normal tissue control from autopsy, 24 cases 48 cores, with grade and stage status |
US Biomax |
|
160€ |
|
Pub |
LC726 Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016 US Biomax 231 |
LC726 |
Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016 |
US Biomax |
|
231€ |
|
Pub |
LC991 Lung squamous cell carcinoma (grade I III) tissue array with matched tumor adjacent and normal control, 33 cases 99 cores US Biomax 231 |
LC991 |
Lung squamous cell carcinoma (grade I III) tissue array with matched tumor adjacent and normal control, 33 cases 99 cores |
US Biomax |
|
231€ |
|
Pub |
LV721 Hepatocellular carcinoma and normal tissue array with stage and grade information, 24 cases 72 cores US Biomax 231 |
LV721 |
Hepatocellular carcinoma and normal tissue array with stage and grade information, 24 cases 72 cores |
US Biomax |
|
231€ |
|
Pub |
LV809 Hepatocellular carcinoma and normal tissue array, with stage, TNM and grade, 80 cases 80 cores, replacing BS03014 US Biomax 231 |
LV809 |
Hepatocellular carcinoma and normal tissue array, with stage, TNM and grade, 80 cases 80 cores, replacing BS03014 |
US Biomax |
|
231€ |
|
Pub |
LVN801 Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011 US Biomax 231 |
LVN801 |
Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011 |
US Biomax |
|
231€ |
|
Pub |
OR208 Oral cavity squamous cell carcinoma and normal tissues high density (69 cases 208 cores) tissue microarray) with grade and stage info US Biomax 456 |
OR208 |
Oral cavity squamous cell carcinoma and normal tissues high density (69 cases 208 cores) tissue microarray) with grade and stage info |
US Biomax |
|
456€ |
|
Pub |
RE722 Rectal cancer tissue array with matched adjacent normal tissue, including stage and grade info, 24 cases 72 cores, replacing BC06022 US Biomax 231 |
RE722 |
Rectal cancer tissue array with matched adjacent normal tissue, including stage and grade info, 24 cases 72 cores, replacing BC06022 |
US Biomax |
|
231€ |
|
Pub |
SK801b Skin squamous cell carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing SK801 US Biomax 321 |
SK801b |
Skin squamous cell carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing SK801 |
US Biomax |
|
321€ |
|
Pub |
ST723 Stomach poorly differentiated adenocarcinoma tissue array with adjacent normal control, stage and grade info, 24 cases 72 cores, replacing BS01042 US Biomax 231 |
ST723 |
Stomach poorly differentiated adenocarcinoma tissue array with adjacent normal control, stage and grade info, 24 cases 72 cores, replacing BS01042 |
US Biomax |
|
231€ |
|
Pub |
BC02022 Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores US Biomax 160 |
BC02022 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores |
US Biomax |
|
160€ |
|
Pub |
BC03116 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores US Biomax 231 |
BC03116 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases 70 cores |
US Biomax |
|
231€ |
|
Pub |
BC03118 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 |
BC03118 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC03119 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 |
BC03119 |
Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores |
US Biomax |
|
278€ |
|
Pub |
BC041114 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 |
BC041114 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC041115 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 |
BC041115 |
Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores |
US Biomax |
|
278€ |
|
Pub |
BC041115a Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed US Biomax 296 |
BC041115a |
Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BC05118a Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed US Biomax 296 |
BC05118a |
Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BC07014a Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed US Biomax 185 |
BC07014a |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BC11012a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed US Biomax 185 |
BC11012a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BC19021 Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases 72 cores US Biomax 266 |
BC19021 |
Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases 72 cores |
US Biomax |
|
266€ |
|
Pub |
BCN963a Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed US Biomax 258 |
BCN963a |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BN05014 Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases 72 cores, replacing BN05011 US Biomax 160 |
BN05014 |
Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases 72 cores, replacing BN05011 |
US Biomax |
|
160€ |
|
Pub |
BR1005a Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed US Biomax 296 |
BR1005a |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BR1008 Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212 US Biomax 266 |
BR1008 |
Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212 |
US Biomax |
|
266€ |
|
Pub |
BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 US Biomax 456 |
BR2086 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001 |
US Biomax |
|
456€ |
|
Pub |
BR243a Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243 US Biomax 99 |
BR243a |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243 |
US Biomax |
|
99€ |
|
Pub |
BR243b Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed US Biomax 90 |
BR243b |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR243d Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed US Biomax 90 |
BR243d |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR243e Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90 |
BR243e |
Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR243f Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90 |
BR243f |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 US Biomax 231 |
BR8014 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012 |
US Biomax |
|
231€ |
|
Pub |
BR953 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952 US Biomax 456 |
BR953 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952 |
US Biomax |
|
456€ |
|
Pub |
BR954 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc US Biomax 429 |
BR954 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc |
US Biomax |
|
429€ |
|
Pub |
BRN801a Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed US Biomax 258 |
BRN801a |
Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BS02021 Esophagus squamous cell carcinoma (grade I) tissue array, 21 cases 63 cores US Biomax 160 |
BS02021 |
Esophagus squamous cell carcinoma (grade I) tissue array, 21 cases 63 cores |
US Biomax |
|
160€ |
|
Pub |
BS02031 Esophagus squamous cell carcinoma (grade II) tissue array, 22 cases 63 cores, replaced by ES723 US Biomax 160 |
BS02031 |
Esophagus squamous cell carcinoma (grade II) tissue array, 22 cases 63 cores, replaced by ES723 |
US Biomax |
|
160€ |
|
Pub |
BS04041 Lung squamous cell carcinoma (grade II) tissue array, 21 cases 63 cores US Biomax 160 |
BS04041 |
Lung squamous cell carcinoma (grade II) tissue array, 21 cases 63 cores |
US Biomax |
|
160€ |
|
Pub |
BS04071 Lung squamous cell carcinoma (grade III) tissue array, 21 cases 63 cores, replaced by LC723 US Biomax 160 |
BS04071 |
Lung squamous cell carcinoma (grade III) tissue array, 21 cases 63 cores, replaced by LC723 |
US Biomax |
|
160€ |
|
Pub |
CO1002b Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002 US Biomax 321 |
CO1002b |
Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002 |
US Biomax |
|
321€ |
|
Pub |
CO241a Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed US Biomax 105 |
CO241a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
CO484a Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed US Biomax 210 |
CO484a |
Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
CO952 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi US Biomax 429 |
CO952 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi |
US Biomax |
|
429€ |
|
Pub |
CR484 Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases 48 cores US Biomax 225 |
CR484 |
Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
225€ |
|
Pub |
CR721 Uterine cervix cancer and normal tissue array, with grade and stage data, 24 cases 72 cores US Biomax 231 |
CR721 |
Uterine cervix cancer and normal tissue array, with grade and stage data, 24 cases 72 cores |
US Biomax |
|
231€ |
|
Pub |
ES1202 Esophageal tumor tissue array, with stage, grade and matched adjacent tissue, 60 cases 120 cores, replacing ES1201 US Biomax 278 |
ES1202 |
Esophageal tumor tissue array, with stage, grade and matched adjacent tissue, 60 cases 120 cores, replacing ES1201 |
US Biomax |
|
278€ |
|
Pub |
ES1501 Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores US Biomax 321 |
ES1501 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores |
US Biomax |
|
321€ |
|
Pub |
ES481 Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmed US Biomax 210 |
ES481 |
Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
ES8010 Esophageal cancer and adjacent normal tissue array, with TNM and grade info, 40 cases 80 cores, replacing ES801 US Biomax 231 |
ES8010 |
Esophageal cancer and adjacent normal tissue array, with TNM and grade info, 40 cases 80 cores, replacing ES801 |
US Biomax |
|
231€ |
|
Pub |
ES807 Esophageal cancer and normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 231 |
ES807 |
Esophageal cancer and normal tissue array, with stage and grade info, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
ES811 Esophageal cancer tissue array with normal tissues from autopsy, 40 cases 80 cores, plus grade and stage information US Biomax 231 |
ES811 |
Esophageal cancer tissue array with normal tissues from autopsy, 40 cases 80 cores, plus grade and stage information |
US Biomax |
|
231€ |
|
Pub |
ES961 Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores US Biomax 336 |
ES961 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores |
US Biomax |
|
336€ |
|
Pub |
FDA807-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2 US Biomax 336 |
FDA807-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2 |
US Biomax |
|
336€ |
|
Pub |
FDA808-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2 US Biomax 277 |
FDA808-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2 |
US Biomax |
|
277€ |
|
Pub |
HN241a Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed US Biomax 90 |
HN241a |
Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
HN803a Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed US Biomax 296 |
HN803a |
Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
HN811 Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111 US Biomax 266 |
HN811 |
Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111 |
US Biomax |
|
266€ |
|
Pub |
KD481 Tissue array of kidney clear cell carcinoma and matched adjacent tissue, with stage and grade data, 12 cases 48 cores US Biomax 160 |
KD481 |
Tissue array of kidney clear cell carcinoma and matched adjacent tissue, with stage and grade data, 12 cases 48 cores |
US Biomax |
|
160€ |
|
Pub |
KD951 Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases 95 cores US Biomax 456 |
KD951 |
Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases 95 cores |
US Biomax |
|
456€ |
|
Pub |
LC10010a Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed US Biomax 296 |
LC10010a |
Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
LC10011 Non small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
LC10011 |
Non small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
LC10012 Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006 US Biomax 266 |
LC10012 |
Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006 |
US Biomax |
|
266€ |
|
Pub |
LC1009 Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 231 |
LC1009 |
Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
LC1921 High density non small cell lung carcinoma (NSCLC) tissue array, with stage and grade info, 192 cases 192 cores US Biomax 456 |
LC1921 |
High density non small cell lung carcinoma (NSCLC) tissue array, with stage and grade info, 192 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
LC1922 Middle advanced stage lung non small cell carcinoma tissue array, including TNM and pathology grade, 96 cases 192 cores US Biomax 456 |
LC1922 |
Middle advanced stage lung non small cell carcinoma tissue array, including TNM and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
LC721 Non small cell lung carcinoma (NSCLC) tissue array, 24 cases 72 cores, replacing BC04011 US Biomax 231 |
LC721 |
Non small cell lung carcinoma (NSCLC) tissue array, 24 cases 72 cores, replacing BC04011 |
US Biomax |
|
231€ |
|
Pub |
LC723 Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04071 US Biomax 231 |
LC723 |
Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04071 |
US Biomax |
|
231€ |
|
Pub |
LC724 Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04031 US Biomax 231 |
LC724 |
Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04031 |
US Biomax |
|
231€ |
|
Pub |
LC726a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed US Biomax 228 |
LC726a |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
LC727 Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 cores US Biomax 231 |
LC727 |
Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 cores |
US Biomax |
|
231€ |
|
Pub |
LC813 Multiple non small cell lung carcinoma (NSCLC) and small cell lung carcinoma tissue array with normal lung tissue, 77 cases 80 cores, replacing BC04014 US Biomax 231 |
LC813 |
Multiple non small cell lung carcinoma (NSCLC) and small cell lung carcinoma tissue array with normal lung tissue, 77 cases 80 cores, replacing BC04014 |
US Biomax |
|
231€ |
|
Pub |
LV481 Liver cancer tissue array with normal adjacent tissues, 23 cases 48 cores, with grade and stage data US Biomax 160 |
LV481 |
Liver cancer tissue array with normal adjacent tissues, 23 cases 48 cores, with grade and stage data |
US Biomax |
|
160€ |
|
Pub |
LV723 Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013 US Biomax 231 |
LV723 |
Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013 |
US Biomax |
|
231€ |
|
Pub |
LV8010 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011 US Biomax 231 |
LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011 |
US Biomax |
|
231€ |
|
Pub |
LV8010 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed US Biomax 296 |
LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
MC245 Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 US Biomax 88 |
MC245 |
Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242 |
US Biomax |
|
88€ |
|
Pub |
MC246 Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed US Biomax 90 |
MC246 |
Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
MC483 Multiple types of cancer tissue array with normal control, replacing BC00119, 26 cases 48 cores, with stage and grade data US Biomax 160 |
MC483 |
Multiple types of cancer tissue array with normal control, replacing BC00119, 26 cases 48 cores, with stage and grade data |
US Biomax |
|
160€ |
|
Pub |
MC5002 High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001 US Biomax 634 |
MC5002 |
High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001 |
US Biomax |
|
634€ |
|
Pub |
MC809a Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed US Biomax 382 |
MC809a |
Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed |
US Biomax |
|
382€ |
|
Pub |
MCN602 Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601 US Biomax 231 |
MCN602 |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601 |
US Biomax |
|
231€ |
|
Pub |
OV241a Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed US Biomax 105 |
OV241a |
Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
OV701 Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed US Biomax 228 |
OV701 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
OV802 Multiple ovarian carcinoma and normal tissue array, with stage and TNM info, 78 cases 80 cores, replacing BC11011 US Biomax 231 |
OV802 |
Multiple ovarian carcinoma and normal tissue array, with stage and TNM info, 78 cases 80 cores, replacing BC11011 |
US Biomax |
|
231€ |
|
Pub |
PA242a Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed US Biomax 105 |
PA242a |
Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
PA805a Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed US Biomax 296 |
PA805a |
Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
PA961a Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed US Biomax 258 |
PA961a |
Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
PR242a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed US Biomax 105 |
PR242a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
PR243 Prostate cancer and normal tissue array, with stage and grade info, 12 cases 24 cores, replacing PR241 US Biomax 88 |
PR243 |
Prostate cancer and normal tissue array, with stage and grade info, 12 cases 24 cores, replacing PR241 |
US Biomax |
|
88€ |
|
Pub |
PR243a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed US Biomax 105 |
PR243a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
PR808 Prostate cancer and normal tissue array, with TNM, stage, Gleason's score and grade info, 40 cases 80 cores, replacing BC19012 US Biomax 266 |
PR808 |
Prostate cancer and normal tissue array, with TNM, stage, Gleason's score and grade info, 40 cases 80 cores, replacing BC19012 |
US Biomax |
|
266€ |
|
Pub |
RE723 Rectal adenocarcinoma (grade 2) tissue array, with stage, TNM and grade, 24 cases 72 cores, replacing BS06031 US Biomax 231 |
RE723 |
Rectal adenocarcinoma (grade 2) tissue array, with stage, TNM and grade, 24 cases 72 cores, replacing BS06031 |
US Biomax |
|
231€ |
|
Pub |
RE724 Rectal adenocarcinoma (grade 3) tissue array, with stage, TNM and grade info, 24 cases 72 cores, replacing BS06041 US Biomax 231 |
RE724 |
Rectal adenocarcinoma (grade 3) tissue array, with stage, TNM and grade info, 24 cases 72 cores, replacing BS06041 |
US Biomax |
|
231€ |
|
Pub |
SK483 Multiple skin squamous cell carcinoma tissue array with normal tissues control from autopsy, 48 cases 48 cores US Biomax 160 |
SK483 |
Multiple skin squamous cell carcinoma tissue array with normal tissues control from autopsy, 48 cases 48 cores |
US Biomax |
|
160€ |
|
Pub |
SK721 Skin cancer and normal tissue array, with stage and grade info, 24 cases 72 cores US Biomax 266 |
SK721 |
Skin cancer and normal tissue array, with stage and grade info, 24 cases 72 cores |
US Biomax |
|
266€ |
|
Pub |
ST721 Stomach adenocarcinoma and normal tissue array with TNM and pathology grade data, 24 cases 72 cores, replacing BC01011 US Biomax 231 |
ST721 |
Stomach adenocarcinoma and normal tissue array with TNM and pathology grade data, 24 cases 72 cores, replacing BC01011 |
US Biomax |
|
231€ |
|
Pub |
ST722 Stomach adenocarcinoma with self matched adjacent and normal tissue array, with stage and grade info, 24 cases 72 cores US Biomax 231 |
ST722 |
Stomach adenocarcinoma with self matched adjacent and normal tissue array, with stage and grade info, 24 cases 72 cores |
US Biomax |
|
231€ |
|
Pub |
T022 Esophageal cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T022 |
Esophageal cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T045b Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045 US Biomax 99 |
T045b |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045 |
US Biomax |
|
99€ |
|
Pub |
T054a Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed US Biomax 90 |
T054a |
Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T084 Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases 24 cores, replacing T082 US Biomax 88 |
T084 |
Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases 24 cores, replacing T082 |
US Biomax |
|
88€ |
|
Pub |
T087a Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed US Biomax 90 |
T087a |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T112a Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed US Biomax 90 |
T112a |
Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T113a Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed US Biomax 90 |
T113a |
Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T212a Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed US Biomax 90 |
T212a |
Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
TH721 Thyroid cancer and normal tissue array with clinical stage and grade info, 24 cases 72 cores US Biomax 266 |
TH721 |
Thyroid cancer and normal tissue array with clinical stage and grade info, 24 cases 72 cores |
US Biomax |
|
266€ |
|
Pub |
UT721 Endometrioid adenocarcinoma and normal tissue array with clinical stage and grade information, 24 cases 72 cores US Biomax 266 |
UT721 |
Endometrioid adenocarcinoma and normal tissue array with clinical stage and grade information, 24 cases 72 cores |
US Biomax |
|
266€ |
|
Pub |
UT803 Endometrioid carcinoma, adjacent and normal tissue array, with grade and stage information, 40 cases 80 cores US Biomax 266 |
UT803 |
Endometrioid carcinoma, adjacent and normal tissue array, with grade and stage information, 40 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
BC000119 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456 |
BC000119 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC000120 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456 |
BC000120 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC00019 Multiple organ squamous cell carcinoma tissue array, 63 cases 63 cores US Biomax 231 |
BC00019 |
Multiple organ squamous cell carcinoma tissue array, 63 cases 63 cores |
US Biomax |
|
231€ |
|
Pub |
BC001130 Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores US Biomax 278 |
BC001130 |
Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores |
US Biomax |
|
278€ |
|
Pub |
BC001134 Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores US Biomax 397 |
BC001134 |
Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores |
US Biomax |
|
397€ |
|
Pub |
BC01071a Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed US Biomax 185 |
BC01071a |
Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BC01114 Stomach adenocarcinoma with matched adjacent tissue and normal tissue array, including TNM, clinical stage and pathology grade, 55 cases 100 cores US Biomax 231 |
BC01114 |
Stomach adenocarcinoma with matched adjacent tissue and normal tissue array, including TNM, clinical stage and pathology grade, 55 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
BC02012 Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores US Biomax 160 |
BC02012 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores |
US Biomax |
|
160€ |
|
Pub |
BC02013 Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores US Biomax 160 |
BC02013 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores |
US Biomax |
|
160€ |
|
Pub |
BC02021 Esophagus squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores US Biomax 160 |
BC02021 |
Esophagus squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores |
US Biomax |
|
160€ |
|
Pub |
BC02023 Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54cores, replaced by ES722 US Biomax 160 |
BC02023 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54cores, replaced by ES722 |
US Biomax |
|
160€ |
|
Pub |
BC04022 Non small cell lung carcinoma (NSCLC)(combination of adjacent and normal) tissue array, 18 cases 54 cores US Biomax 160 |
BC04022 |
Non small cell lung carcinoma (NSCLC)(combination of adjacent and normal) tissue array, 18 cases 54 cores |
US Biomax |
|
160€ |
|
Pub |
BC04119 Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b US Biomax 231 |
BC04119 |
Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b |
US Biomax |
|
231€ |
|
Pub |
BC04119b Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119 US Biomax 336 |
BC04119b |
Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119 |
US Biomax |
|
336€ |
|
Pub |
BC05023 Colon adenocarcinoma (combination of adjacent and normal) tissue array, with grade and stage (TNM) info, 18 cases 54 cores US Biomax 231 |
BC05023 |
Colon adenocarcinoma (combination of adjacent and normal) tissue array, with grade and stage (TNM) info, 18 cases 54 cores |
US Biomax |
|
231€ |
|
Pub |
BC051110 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores US Biomax 278 |
BC051110 |
Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases 120 cores |
US Biomax |
|
278€ |
|
Pub |
BC051111 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores US Biomax 456 |
BC051111 |
Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC05115 Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702 US Biomax 231 |
BC05115 |
Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases 69 cores, replaced by CO702 |
US Biomax |
|
231€ |
|
Pub |
BC05118 Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266 |
BC05118 |
Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BC07013 Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011 US Biomax 160 |
BC07013 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011 |
US Biomax |
|
160€ |
|
Pub |
BC07015 Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012 US Biomax 231 |
BC07015 |
Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012 |
US Biomax |
|
231€ |
|
Pub |
BC07114 Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases 200 cores US Biomax 558 |
BC07114 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases 200 cores |
US Biomax |
|
558€ |
|
Pub |
BC07115 Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 120 cases 120 cores US Biomax 321 |
BC07115 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 120 cases 120 cores |
US Biomax |
|
321€ |
|
Pub |
BC08022 Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases 63 cores, replacing BN08021 US Biomax 160 |
BC08022 |
Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases 63 cores, replacing BN08021 |
US Biomax |
|
160€ |
|
Pub |
BC081120 Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115 US Biomax 266 |
BC081120 |
Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115 |
US Biomax |
|
266€ |
|
Pub |
BC10021 Cervix carcinoma (combination of margin and normal tissues) tissue array, 64 cases 72 cores US Biomax 231 |
BC10021 |
Cervix carcinoma (combination of margin and normal tissues) tissue array, 64 cases 72 cores |
US Biomax |
|
231€ |
|
Pub |
BC110118 Ovarian cancer tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC11012 US Biomax 231 |
BC110118 |
Ovarian cancer tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC11012 |
US Biomax |
|
231€ |
|
Pub |
BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed US Biomax 162 |
BC12011a |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed |
US Biomax |
|
162€ |
|
Pub |
BC21011 Skin malignant tumor tissue array, 78 cases 78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014 US Biomax 231 |
BC21011 |
Skin malignant tumor tissue array, 78 cases 78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014 |
US Biomax |
|
231€ |
|
Pub |
BC34011 Head and neck squamous cell carcinoma tissue array, 24 cases 63 cores US Biomax 160 |
BC34011 |
Head and neck squamous cell carcinoma tissue array, 24 cases 63 cores |
US Biomax |
|
160€ |
|
Pub |
BCN963 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961 US Biomax 266 |
BCN963 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961 |
US Biomax |
|
266€ |
|
Pub |
BL243 Bladder cancer tissue array with normal tissues from autopsy, 12 cases 24 cores with stage and grade data US Biomax 100 |
BL243 |
Bladder cancer tissue array with normal tissues from autopsy, 12 cases 24 cores with stage and grade data |
US Biomax |
|
100€ |
|
Pub |
BL481 Bladder cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with stage and grade data US Biomax 189 |
BL481 |
Bladder cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with stage and grade data |
US Biomax |
|
189€ |
|
Pub |
BL801 Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases 80 cores, replaced by BL806 US Biomax 266 |
BL801 |
Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases 80 cores, replaced by BL806 |
US Biomax |
|
266€ |
|
Pub |
BL806 Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801 US Biomax 266 |
BL806 |
Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801 |
US Biomax |
|
266€ |
|
Pub |
BM483 Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases 48 cores, replacing BM482 US Biomax 266 |
BM483 |
Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases 48 cores, replacing BM482 |
US Biomax |
|
266€ |
|
Pub |
BN01011b Normal stomach tissue array, 24 cases 72 cores, replacing BN01011 US Biomax 277 |
BN01011b |
Normal stomach tissue array, 24 cases 72 cores, replacing BN01011 |
US Biomax |
|
277€ |
|
Pub |
BR10010 Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004 US Biomax 314 |
BR10010 |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004 |
US Biomax |
|
314€ |
|
Pub |
BR10010a Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme US Biomax 296 |
BR10010a |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme |
US Biomax |
|
296€ |
|
Pub |
BR1503a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti- US Biomax 296 |
BR1503a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti- |
US Biomax |
|
296€ |
|
Pub |
BR2083 High density breast cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores US Biomax 456 |
BR2083 |
High density breast cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR2085c Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a US Biomax 456 |
BR2085c |
Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a |
US Biomax |
|
456€ |
|
Pub |
BR243c Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed US Biomax 90 |
BR243c |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR245 Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246 US Biomax 88 |
BR245 |
Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by BR246 |
US Biomax |
|
88€ |
|
Pub |
BR246a Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246 US Biomax 99 |
BR246a |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246 |
US Biomax |
|
99€ |
|
Pub |
BR482 Multiple breast cancer tissue array with normal tissues from autopsy, 24 cases 48 cores, with stage and grade info US Biomax 160 |
BR482 |
Multiple breast cancer tissue array with normal tissues from autopsy, 24 cases 48 cores, with stage and grade info |
US Biomax |
|
160€ |
|
Pub |
BR486 Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases 48 cores US Biomax 225 |
BR486 |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
225€ |
|
Pub |
BR6161 High density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases 616 cores US Biomax 753 |
BR6161 |
High density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases 616 cores |
US Biomax |
|
753€ |
|
Pub |
BR726 Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases 72 cores US Biomax 231 |
BR726 |
Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases 72 cores |
US Biomax |
|
231€ |
|
Pub |
BR8012 Breast cancer and normal tissue array with stage and grade info, 40 cases 80 cores, replaced by BR8014 US Biomax 231 |
BR8012 |
Breast cancer and normal tissue array with stage and grade info, 40 cases 80 cores, replaced by BR8014 |
US Biomax |
|
231€ |
|
Pub |
BR8013 Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases 80 cores US Biomax 231 |
BR8013 |
Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
BR8015 Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014 US Biomax 231 |
BR8015 |
Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014 |
US Biomax |
|
231€ |
|
Pub |
BR8018 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014 US Biomax 266 |
BR8018 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014 |
US Biomax |
|
266€ |
|
Pub |
BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed US Biomax 258 |
BR803a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed US Biomax 267 |
BR804a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
BR811 Breast cancer tissue array with normal tissues from autopsy, 80 cases 80 cores, with grade and stage data US Biomax 231 |
BR811 |
Breast cancer tissue array with normal tissues from autopsy, 80 cases 80 cores, with grade and stage data |
US Biomax |
|
231€ |
|
Pub |
BR951 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95 US Biomax 456 |
BR951 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95 |
US Biomax |
|
456€ |
|
Pub |
BR952 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores US Biomax 456 |
BR952 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores |
US Biomax |
|
456€ |
|
Pub |
BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 US Biomax 314 |
BR963 |
Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 |
US Biomax |
|
314€ |
|
Pub |
BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed US Biomax 296 |
BR963a |
Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BS04011 Lung squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by LC808 US Biomax 160 |
BS04011 |
Lung squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by LC808 |
US Biomax |
|
160€ |
|
Pub |
BS04031 Lung squamous cell carcinoma tissue array, 63 cases 64 cores, replaced by LC724 US Biomax 160 |
BS04031 |
Lung squamous cell carcinoma tissue array, 63 cases 64 cores, replaced by LC724 |
US Biomax |
|
160€ |
|
Pub |
CO1004 Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 231 |
CO1004 |
Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
CO2083 High density colon cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores US Biomax 456 |
CO2083 |
High density colon cancer tissue array with normal tissue, stage and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CO483 Multiple colon cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade information US Biomax 160 |
CO483 |
Multiple colon cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade information |
US Biomax |
|
160€ |
|
Pub |
CO6161 High density colon cancer array, with stage, grade and normal colon tissue, 322 cases 616 cores US Biomax 753 |
CO6161 |
High density colon cancer array, with stage, grade and normal colon tissue, 322 cases 616 cores |
US Biomax |
|
753€ |
|
Pub |
CO701 Colon cancer tissue array, with grade 1 4 and normal colon tissue, 70 cases 70 cores, with stage and grade information US Biomax 231 |
CO701 |
Colon cancer tissue array, with grade 1 4 and normal colon tissue, 70 cases 70 cores, with stage and grade information |
US Biomax |
|
231€ |
|
Pub |
CO721 Colon cancer tissue array with stage and grade info, 24 cases 72 cores US Biomax 231 |
CO721 |
Colon cancer tissue array with stage and grade info, 24 cases 72 cores |
US Biomax |
|
231€ |
|
Pub |
CO726 Metastatic colon carcinoma tissue array, 24 cases 72 cores, replacing BC050112 US Biomax 266 |
CO726 |
Metastatic colon carcinoma tissue array, 24 cases 72 cores, replacing BC050112 |
US Biomax |
|
266€ |
|
Pub |
CO802a Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed US Biomax 258 |
CO802a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
CO805 Colon adenocarcinoma and normal tissue array with stage and grade information, 40 cases 80 cores US Biomax 231 |
CO805 |
Colon adenocarcinoma and normal tissue array with stage and grade information, 40 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
CO951 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores US Biomax 456 |
CO951 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores |
US Biomax |
|
456€ |
|
Pub |
CR208 Cervical cancer high density tissue array, with normal cervix tissue as control, 69 cases 208 cores, with grade and stage US Biomax 456 |
CR208 |
Cervical cancer high density tissue array, with normal cervix tissue as control, 69 cases 208 cores, with grade and stage |
US Biomax |
|
456€ |
|
Pub |
CR2081 High density cervix cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores US Biomax 456 |
CR2081 |
High density cervix cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR2082 High density cervical cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores US Biomax 456 |
CR2082 |
High density cervical cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
CR244 Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241 US Biomax 189 |
CR244 |
Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241 |
US Biomax |
|
189€ |
|
Pub |
CR481 Cervical cancer tissue array with normal adjacent tissues, 24 cases 48 cores, with grade and stage data US Biomax 160 |
CR481 |
Cervical cancer tissue array with normal adjacent tissues, 24 cases 48 cores, with grade and stage data |
US Biomax |
|
160€ |
|
Pub |
CR482 Multiple cervix cancer tissue array with 4 normal tissues control from autopsy, 24 cases 48 cores, with grade and stage data US Biomax 160 |
CR482 |
Multiple cervix cancer tissue array with 4 normal tissues control from autopsy, 24 cases 48 cores, with grade and stage data |
US Biomax |
|
160€ |
|
Pub |
CR6161 High density uterine cervix cancer array, with stage, grade and normal cervical tissue, 322 cases 616 cores US Biomax 872 |
CR6161 |
High density uterine cervix cancer array, with stage, grade and normal cervical tissue, 322 cases 616 cores |
US Biomax |
|
872€ |
|
Pub |
CR701 Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases 70 cores US Biomax 266 |
CR701 |
Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases 70 cores |
US Biomax |
|
266€ |
|
Pub |
CR805 Cervix cancer and normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 231 |
CR805 |
Cervix cancer and normal tissue array, with stage and grade info, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
ENS2081 Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
ENS2081 |
Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
ES1002 Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores US Biomax 266 |
ES1002 |
Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
ES1201 Tissue array of esophageal squamous carcinoma and matched adjacent tissue, 60 cases 120 cores, replaced by ES1202 US Biomax 278 |
ES1201 |
Tissue array of esophageal squamous carcinoma and matched adjacent tissue, 60 cases 120 cores, replaced by ES1202 |
US Biomax |
|
278€ |
|
Pub |
ES1502 Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
ES1502 |
Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
ES208 High density esophageal cancer tissue array, with normal tissue, grade and TNM, 69 cases 208 cores US Biomax 456 |
ES208 |
High density esophageal cancer tissue array, with normal tissue, grade and TNM, 69 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
ES2082 High density esophageal cancer and normal tissue array, with TNM and grade info, 208 cases 208 cores US Biomax 456 |
ES2082 |
High density esophageal cancer and normal tissue array, with TNM and grade info, 208 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
ES482 Multiple esophagus cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with grade and stage data US Biomax 160 |
ES482 |
Multiple esophagus cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with grade and stage data |
US Biomax |
|
160€ |
|
Pub |
ES721 Esophagus cancer and normal tissue array with TNM and grade info, 24 cases 72 cores US Biomax 231 |
ES721 |
Esophagus cancer and normal tissue array with TNM and grade info, 24 cases 72 cores |
US Biomax |
|
231€ |
|
Pub |
ES8011 Esophageal cancer tissue array, with normal tissue, TNM and grade info, 40 cases 80 cores US Biomax 231 |
ES8011 |
Esophageal cancer tissue array, with normal tissue, TNM and grade info, 40 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
ES8012 Middle advanced stage esophageal cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 278 |
ES8012 |
Middle advanced stage esophageal cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores |
US Biomax |
|
278€ |
|
Pub |
ES805 Esophagus cancer and normal tissue array, with grade and stage data, 40 cases 80 cores US Biomax 231 |
ES805 |
Esophagus cancer and normal tissue array, with grade and stage data, 40 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
FDA805-2 Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2 US Biomax 278 |
FDA805-2 |
Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2 |
US Biomax |
|
278€ |
|
Pub |
FDA808a-1 Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed US Biomax 267 |
FDA808a-1 |
Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
FMC402b Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed US Biomax 626 |
FMC402b |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
GL2083a Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed US Biomax 487 |
GL2083a |
Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed |
US Biomax |
|
487€ |
|
Pub |
GL241a Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed US Biomax 90 |
GL241a |
Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
GL721 Brain tumor and normal tissue array with TNM and grade info, 24 cases 72 cores US Biomax 266 |
GL721 |
Brain tumor and normal tissue array with TNM and grade info, 24 cases 72 cores |
US Biomax |
|
266€ |
|
Pub |
GL803a Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed US Biomax 296 |
GL803a |
Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
GL811 Brain tumor and normal tissue array, with pathology grade, 27 cases 81 cores, replacing BS17011 US Biomax 266 |
GL811 |
Brain tumor and normal tissue array, with pathology grade, 27 cases 81 cores, replacing BS17011 |
US Biomax |
|
266€ |
|
Pub |
HN242a Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed US Biomax 90 |
HN242a |
Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
HN481 Head & Neck cancer tissue array with unmatched normal adjacent tissues, 24 cases 48 cores with stage and grade data US Biomax 160 |
HN481 |
Head & Neck cancer tissue array with unmatched normal adjacent tissues, 24 cases 48 cores with stage and grade data |
US Biomax |
|
160€ |
|
Pub |
HN482 Multiple Head & Neck cancer tissue array with normal tissue from autopsy, 48 cases 48 cores with stage and grade data, replaced by HN483 US Biomax 160 |
HN482 |
Multiple Head & Neck cancer tissue array with normal tissue from autopsy, 48 cases 48 cores with stage and grade data, replaced by HN483 |
US Biomax |
|
160€ |
|
Pub |
HN483 Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482 US Biomax 160 |
HN483 |
Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482 |
US Biomax |
|
160€ |
|
Pub |
HN802 Multiple head and neck tumor with normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 266 |
HN802 |
Multiple head and neck tumor with normal tissue array, with stage and grade info, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
IC00011b Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011 US Biomax 321 |
IC00011b |
Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011 |
US Biomax |
|
321€ |
|
Pub |
KD2083 Kidney cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores US Biomax 456 |
KD2083 |
Kidney cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
KD244 Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
KD244 |
Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
KD482 Tissue array of kidney carcinoma and matched adjacent tissue, with stage and grade data, 24 cases 48 cores US Biomax 160 |
KD482 |
Tissue array of kidney carcinoma and matched adjacent tissue, with stage and grade data, 24 cases 48 cores |
US Biomax |
|
160€ |
|
Pub |
KD483 Multiple Kidney cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade data US Biomax 160 |
KD483 |
Multiple Kidney cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade data |
US Biomax |
|
160€ |
|
Pub |
KD486 Kidney clear cell carcinoma with matched adjacent kidney tissue array, including TNM and pathology grade, 16 cases 48 cores US Biomax 225 |
KD486 |
Kidney clear cell carcinoma with matched adjacent kidney tissue array, including TNM and pathology grade, 16 cases 48 cores |
US Biomax |
|
225€ |
|
Pub |
KD6161 High density renal cancer array, with stage, grade and normal renal tissue, 322 cases 616 cores US Biomax 753 |
KD6161 |
High density renal cancer array, with stage, grade and normal renal tissue, 322 cases 616 cores |
US Biomax |
|
753€ |
|
Pub |
KD804 Multiple types of kidney cancer and normal, adjacent normal tissue array, 80 cases 80 cores, with stage and grade information US Biomax 231 |
KD804 |
Multiple types of kidney cancer and normal, adjacent normal tissue array, 80 cases 80 cores, with stage and grade information |
US Biomax |
|
231€ |
|
Pub |
KD808 Mid advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores US Biomax 231 |
KD808 |
Mid advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
KD961 Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
KD961 |
Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LC10010 Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores US Biomax 231 |
LC10010 |
Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores |
US Biomax |
|
231€ |
|
Pub |
LC10013 Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1002 US Biomax 266 |
LC10013 |
Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1002 |
US Biomax |
|
266€ |
|
Pub |
LC2084 High density Lung cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores US Biomax 456 |
LC2084 |
High density Lung cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LC241 Non small cell lung carcinoma (NSCLC) test tissue array, with self matching normal adjacent tissue, 6 cases 24 cores US Biomax 88 |
LC241 |
Non small cell lung carcinoma (NSCLC) test tissue array, with self matching normal adjacent tissue, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
LC242 Non small cell lung carcinoma (NSCLC) test tissue array, with unmatched normal adjacent tissue, 12 cases 24 cores US Biomax 88 |
LC242 |
Non small cell lung carcinoma (NSCLC) test tissue array, with unmatched normal adjacent tissue, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
LC6161 High density lung cancer array, with stage, grade and normal lung tissue, 322 cases 616 cores US Biomax 753 |
LC6161 |
High density lung cancer array, with stage, grade and normal lung tissue, 322 cases 616 cores |
US Biomax |
|
753€ |
|
Pub |
LC722 Lung cancer and normal tissue array, with TNM and grade data, 24 cases 72 cores US Biomax 231 |
LC722 |
Lung cancer and normal tissue array, with TNM and grade data, 24 cases 72 cores |
US Biomax |
|
231€ |
|
Pub |
LC725 Normal lung tissue array, 24 cases 72 cores, replacing BN04011 US Biomax 278 |
LC725 |
Normal lung tissue array, 24 cases 72 cores, replacing BN04011 |
US Biomax |
|
278€ |
|
Pub |
LC807 Lung cancer and normal tissue array, with TNM and grade info, 77 cases 80 cores, replacing BC04014 US Biomax 231 |
LC807 |
Lung cancer and normal tissue array, with TNM and grade info, 77 cases 80 cores, replacing BC04014 |
US Biomax |
|
231€ |
|
Pub |
LC815 Lung cancer and normal tissue array with stage and grade info, 40 cases 80 cores US Biomax 231 |
LC815 |
Lung cancer and normal tissue array with stage and grade info, 40 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
LC816 Advanced lung cancer and normal tissue array, with stage TNM and grade info, 80 cases 80 cores US Biomax 231 |
LC816 |
Advanced lung cancer and normal tissue array, with stage TNM and grade info, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
LC951 Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases 95 cores US Biomax 456 |
LC951 |
Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases 95 cores |
US Biomax |
|
456€ |
|
Pub |
LP481 Larynx and pharynx cancer tissue array with unmatched normal tissues, 48 cases 48, cores with stage and grade data US Biomax 160 |
LP481 |
Larynx and pharynx cancer tissue array with unmatched normal tissues, 48 cases 48, cores with stage and grade data |
US Biomax |
|
160€ |
|
Pub |
LP721 Laryngeal cancer and normal tissue array, with grade and TNM information, 24 cases 72 cores US Biomax 266 |
LP721 |
Laryngeal cancer and normal tissue array, with grade and TNM information, 24 cases 72 cores |
US Biomax |
|
266€ |
|
Pub |
LP803 Laryngeal squamous cell carcinoma tissue array, 80 cases 80 cores US Biomax 266 |
LP803 |
Laryngeal squamous cell carcinoma tissue array, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
LP804 Laryngeal cancerous, cancer adjacent and normal tissue array, with grade and stage info, 40 cases 80 cores US Biomax 266 |
LP804 |
Laryngeal cancerous, cancer adjacent and normal tissue array, with grade and stage info, 40 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
LV208 Liver cancer (hepatocellular carcinoma) and normal tissue high density (69 cases 208 cores) tissue microarray, with stage and grade info US Biomax 456 |
LV208 |
Liver cancer (hepatocellular carcinoma) and normal tissue high density (69 cases 208 cores) tissue microarray, with stage and grade info |
US Biomax |
|
456€ |
|
Pub |
LV2083 High density liver cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores US Biomax 456 |
LV2083 |
High density liver cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
LV2091 Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed US Biomax 429 |
LV2091 |
Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed |
US Biomax |
|
429€ |
|
Pub |
LV243 Liver cancer tissue array with normal tissues from autopsy, 12 cases 24 cores, with grade and stage US Biomax 88 |
LV243 |
Liver cancer tissue array with normal tissues from autopsy, 12 cases 24 cores, with grade and stage |
US Biomax |
|
88€ |
|
Pub |
LV6161 High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 cores US Biomax 753 |
LV6161 |
High density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases 616 cores |
US Biomax |
|
753€ |
|
Pub |
LV803 Liver carcinoma (combination of cancer, cancer adjacent and normal tissue), 53 cases 72 cores, replacing BC03021 US Biomax 231 |
LV803 |
Liver carcinoma (combination of cancer, cancer adjacent and normal tissue), 53 cases 72 cores, replacing BC03021 |
US Biomax |
|
231€ |
|
Pub |
LV808 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 231 |
LV808 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
LY802 Lymph node metastatic squamous cell carcinoma tissue array, 80 cases 80 cores US Biomax 266 |
LY802 |
Lymph node metastatic squamous cell carcinoma tissue array, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
MC2501 Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases 250 cores US Biomax 516 |
MC2501 |
Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases 250 cores |
US Biomax |
|
516€ |
|
Pub |
MC5001 High density (495 cases 500 cores) tissue array of multiple organ cancer and normal, with stage and grade information, replaced by MC5002 US Biomax 634 |
MC5001 |
High density (495 cases 500 cores) tissue array of multiple organ cancer and normal, with stage and grade information, replaced by MC5002 |
US Biomax |
|
634€ |
|
Pub |
MC5003 High density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases 500 cores, replacing MC5002 US Biomax 634 |
MC5003 |
High density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases 500 cores, replacing MC5002 |
US Biomax |
|
634€ |
|
Pub |
MC616 High density lung, breast, brain and colon cancer array, with stage, grade and normal tissue array, 308 cases 616 cores US Biomax 753 |
MC616 |
High density lung, breast, brain and colon cancer array, with stage, grade and normal tissue array, 308 cases 616 cores |
US Biomax |
|
753€ |
|
Pub |
MC6162 High density stomach, colonrectal cancer tissue array, with stage, grade and normal tissue, 616 cases 616 cores US Biomax 753 |
MC6162 |
High density stomach, colonrectal cancer tissue array, with stage, grade and normal tissue, 616 cases 616 cores |
US Biomax |
|
753€ |
|
Pub |
MC6163 High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed US Biomax 811 |
MC6163 |
High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed |
US Biomax |
|
811€ |
|
Pub |
MC641 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115 US Biomax 0 |
MC641 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115 |
US Biomax |
|
0€ |
|
Pub |
MC802 Multiple cancer tissue array with matched or unmatched normal control, replacing BC00115, 44 cases 80 cores, with grade information US Biomax 266 |
MC802 |
Multiple cancer tissue array with matched or unmatched normal control, replacing BC00115, 44 cases 80 cores, with grade information |
US Biomax |
|
266€ |
|
Pub |
MC803a Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed US Biomax 320 |
MC803a |
Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed |
US Biomax |
|
320€ |
|
Pub |
MC964 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961 US Biomax 266 |
MC964 |
Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961 |
US Biomax |
|
266€ |
|
Pub |
ME241a Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed US Biomax 105 |
ME241a |
Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
ME481a Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed US Biomax 185 |
ME481a |
Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
ME803a Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed US Biomax 296 |
ME803a |
Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
MGS801 Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores US Biomax 266 |
MGS801 |
Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
MS481a Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed US Biomax 296 |
MS481a |
Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
OS802 Osteosarcoma and chondrosarcoma tissue array, with stage, grade and TNM data, 80 cases 80 cores, replacing BC26111 US Biomax 266 |
OS802 |
Osteosarcoma and chondrosarcoma tissue array, with stage, grade and TNM data, 80 cases 80 cores, replacing BC26111 |
US Biomax |
|
266€ |
|
Pub |
OS804 Osteosarcoma tissue tissue array, with stage and grade, 40 cases 80 cores, replacing BS26011 US Biomax 266 |
OS804 |
Osteosarcoma tissue tissue array, with stage and grade, 40 cases 80 cores, replacing BS26011 |
US Biomax |
|
266€ |
|
Pub |
OV1005 Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 US Biomax 266 |
OV1005 |
Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001 |
US Biomax |
|
266€ |
|
Pub |
OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267 |
OV1005a |
Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
OV2083 High density ovarian cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores US Biomax 456 |
OV2083 |
High density ovarian cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
OV2084 Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814 US Biomax 456 |
OV2084 |
Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases 208 cores, replaced by OV20814 |
US Biomax |
|
456€ |
|
Pub |
OV481 Ovarian cancer tissue array with unmatched normal adjacent tissues, 24 cases 48 cores, with stage and grade data US Biomax 160 |
OV481 |
Ovarian cancer tissue array with unmatched normal adjacent tissues, 24 cases 48 cores, with stage and grade data |
US Biomax |
|
160€ |
|
Pub |
OV482 Multiple ovarian cancer tissue array with 4 normal tissues control from autopsy, (24 cases 48 cores) with grade and stage info US Biomax 160 |
OV482 |
Multiple ovarian cancer tissue array with 4 normal tissues control from autopsy, (24 cases 48 cores) with grade and stage info |
US Biomax |
|
160€ |
|
Pub |
OV483 Multiple ovarian cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade info US Biomax 160 |
OV483 |
Multiple ovarian cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade info |
US Biomax |
|
160€ |
|
Pub |
OV803a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed US Biomax 258 |
OV803a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
OV809 Ovary cancer and normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 266 |
OV809 |
Ovary cancer and normal tissue array, with stage and grade info, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
OV811 Ovarian cancer tissue array with normal tissues from autopsy, 35 cases 80 cores, with stage and grade data US Biomax 231 |
OV811 |
Ovarian cancer tissue array with normal tissues from autopsy, 35 cases 80 cores, with stage and grade data |
US Biomax |
|
231€ |
|
Pub |
OV951 Ovary cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 38 cases 95 cores, US Biomax 456 |
OV951 |
Ovary cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 38 cases 95 cores, |
US Biomax |
|
456€ |
|
Pub |
PA2072 Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases 207 cores, replacing PA207 US Biomax 456 |
PA2072 |
Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases 207 cores, replacing PA207 |
US Biomax |
|
456€ |
|
Pub |
PA2082 High density pancreatic cancer and normal tissue array, with stage and grade info, 101 cases 208 cores US Biomax 456 |
PA2082 |
High density pancreatic cancer and normal tissue array, with stage and grade info, 101 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
PA241b Pancreas adenocarcinoma tissue array with matched adjacent normal pancreas tissue, including TNM and pathology grade, 6 cases 24 cores, replacing PA241 US Biomax 99 |
PA241b |
Pancreas adenocarcinoma tissue array with matched adjacent normal pancreas tissue, including TNM and pathology grade, 6 cases 24 cores, replacing PA241 |
US Biomax |
|
99€ |
|
Pub |
PA483 Multiple pancreatic cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with grade and stage data US Biomax 160 |
PA483 |
Multiple pancreatic cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with grade and stage data |
US Biomax |
|
160€ |
|
Pub |
PA722 Pancreatic cancer and normal tissue array, with TNM and pathology grade, 24 cases 72 cores US Biomax 266 |
PA722 |
Pancreatic cancer and normal tissue array, with TNM and pathology grade, 24 cases 72 cores |
US Biomax |
|
266€ |
|
Pub |
PA801 Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, with stage and grade info, 70 cases 80 cores, replaced by PA802 US Biomax 231 |
PA801 |
Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, with stage and grade info, 70 cases 80 cores, replaced by PA802 |
US Biomax |
|
231€ |
|
Pub |
PA804 Pancreatic cancer and normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 266 |
PA804 |
Pancreatic cancer and normal tissue array, with stage and grade info, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
PA805 Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802 US Biomax 266 |
PA805 |
Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802 |
US Biomax |
|
266€ |
|
Pub |
PA961 Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 cores US Biomax 278 |
PA961 |
Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases 96 cores |
US Biomax |
|
278€ |
|
Pub |
PR483 Multiple prostate cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage, grade and Gleason score info US Biomax 160 |
PR483 |
Multiple prostate cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage, grade and Gleason score info |
US Biomax |
|
160€ |
|
Pub |
PR483a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed US Biomax 210 |
PR483a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
PR631 Prostatic carcinoma tissue array with 3 cases of normal prostate tissue from autopsy, 33 cases 63 cores, with grade and Gleason scores US Biomax 266 |
PR631 |
Prostatic carcinoma tissue array with 3 cases of normal prostate tissue from autopsy, 33 cases 63 cores, with grade and Gleason scores |
US Biomax |
|
266€ |
|
Pub |
PR633 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed US Biomax 296 |
PR633 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
PR721 Prostate cancer normal prostate tissue array with TNM, grade and Gleason scores, 24 cases 72 cores US Biomax 266 |
PR721 |
Prostate cancer normal prostate tissue array with TNM, grade and Gleason scores, 24 cases 72 cores |
US Biomax |
|
266€ |
|
Pub |
PR803a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed US Biomax 296 |
PR803a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
PR807 Prostate cancer, hyperplasia and normal tissue array, with stage (Gleason Scores) and grade info, 79 cases 80 cores US Biomax 266 |
PR807 |
Prostate cancer, hyperplasia and normal tissue array, with stage (Gleason Scores) and grade info, 79 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
PR807a Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed US Biomax 296 |
PR807a |
Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed |
US Biomax |
|
296€ |
|
Pub |
PR809 Prostate cancer and hyperplasia tissue array, with stage and grade, 40 cases 80 cores, replacing BC19019 US Biomax 266 |
PR809 |
Prostate cancer and hyperplasia tissue array, with stage and grade, 40 cases 80 cores, replacing BC19019 |
US Biomax |
|
266€ |
|
Pub |
RE482 Multiple rectal cancer tissue array with normal tissue, stage and grade data, 48 cases 48 cores US Biomax 160 |
RE482 |
Multiple rectal cancer tissue array with normal tissue, stage and grade data, 48 cases 48 cores |
US Biomax |
|
160€ |
|
Pub |
RE812 Rectal cancer tissue array with normal tissue from autopsy, 40 cases 80 cores, with grade and stage data US Biomax 231 |
RE812 |
Rectal cancer tissue array with normal tissue from autopsy, 40 cases 80 cores, with grade and stage data |
US Biomax |
|
231€ |
|
Pub |
SK802 Skin squamous cell carcinoma (SCC) tissue array, 80 cases 80 cores, no overlaps with SK801 US Biomax 231 |
SK802 |
Skin squamous cell carcinoma (SCC) tissue array, 80 cases 80 cores, no overlaps with SK801 |
US Biomax |
|
231€ |
|
Pub |
SK804 Skin cancerous and normal tissue array, with stage and grade info, 40 cases 80 cores US Biomax 266 |
SK804 |
Skin cancerous and normal tissue array, with stage and grade info, 40 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
SM802 Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases 80 cores US Biomax 266 |
SM802 |
Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
SO208 Soft tissue sarcoma high density tissue array with normal controls, 69 cases 208 cores, with grade and stage data US Biomax 456 |
SO208 |
Soft tissue sarcoma high density tissue array with normal controls, 69 cases 208 cores, with grade and stage data |
US Biomax |
|
456€ |
|
Pub |
ST2082 High density stomach cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores US Biomax 456 |
ST2082 |
High density stomach cancer tissue array with normal tissues, with stage and grade info, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
ST2083 Stomach cancer and normal stomach tissue array with stage and grade, 69 cases 208 cores US Biomax 456 |
ST2083 |
Stomach cancer and normal stomach tissue array with stage and grade, 69 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
ST2091 Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed US Biomax 487 |
ST2091 |
Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed |
US Biomax |
|
487€ |
|
Pub |
ST481 Stomach cancer tissue array with corresponding (self matching) normal adjacent tissues (12 cases 48 cores), with stage and grade info US Biomax 160 |
ST481 |
Stomach cancer tissue array with corresponding (self matching) normal adjacent tissues (12 cases 48 cores), with stage and grade info |
US Biomax |
|
160€ |
|
Pub |
ST483 Multiple stomach cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade info US Biomax 160 |
ST483 |
Multiple stomach cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores, with stage and grade info |
US Biomax |
|
160€ |
|
Pub |
ST483a Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 185 |
ST483a |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
ST483b Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 210 |
ST483b |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
ST8012 Stomach adenocarcinoma and normal tissue array, with stage and grade information, 40 cases 80 cores US Biomax 231 |
ST8012 |
Stomach adenocarcinoma and normal tissue array, with stage and grade information, 40 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
ST8014 Stomach cancer and normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 231 |
ST8014 |
Stomach cancer and normal tissue array, with stage and grade info, 80 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
ST801a Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed US Biomax 267 |
ST801a |
Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
ST811 Stomach cancer tissue array with normal tissues from autopsy, 80 cases 80 cores, with grade and stage data US Biomax 231 |
ST811 |
Stomach cancer tissue array with normal tissues from autopsy, 80 cases 80 cores, with grade and stage data |
US Biomax |
|
231€ |
|
Pub |
ST812 Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores US Biomax 231 |
ST812 |
Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
STC1021 Stomach cancer tissue array with normal and gastritis tissue control, having grade and stage info, 102 cases 102 cores US Biomax 225 |
STC1021 |
Stomach cancer tissue array with normal and gastritis tissue control, having grade and stage info, 102 cases 102 cores |
US Biomax |
|
225€ |
|
Pub |
T001a Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed US Biomax 90 |
T001a |
Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T012 Stomach cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T012 |
Stomach cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T013 Stomach cancer test tissue array, with normal stomach tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T013 |
Stomach cancer test tissue array, with normal stomach tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T021 Esophageal cancer tissue array, with normal tissues, TNM and grade info, 6 cases 24 cores US Biomax 88 |
T021 |
Esophageal cancer tissue array, with normal tissues, TNM and grade info, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T023 Esophagus carcer test tissue array, with normal esophagus tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T023 |
Esophagus carcer test tissue array, with normal esophagus tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T024 Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T024 |
Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T031 Liver cancer test tissue array with normal liver tissues, with TNM, stage and grade info, 6 cases 24 cores US Biomax 88 |
T031 |
Liver cancer test tissue array with normal liver tissues, with TNM, stage and grade info, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T032 Liver cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T032 |
Liver cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T032a Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed US Biomax 90 |
T032a |
Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T033 Liver cancer test tissue array, with normal liver tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T033 |
Liver cancer test tissue array, with normal liver tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T041 Lung cancer test tissue array, with normal lung control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T041 |
Lung cancer test tissue array, with normal lung control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T042 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044 US Biomax 88 |
T042 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T044 |
US Biomax |
|
88€ |
|
Pub |
T043 Lung cancer test tissue array, with normal lung tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T043 |
Lung cancer test tissue array, with normal lung tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T044 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045 US Biomax 88 |
T044 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045 |
US Biomax |
|
88€ |
|
Pub |
T045 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b US Biomax 88 |
T045 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b |
US Biomax |
|
88€ |
|
Pub |
T045c Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed US Biomax 90 |
T045c |
Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T047 Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T047 |
Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T051 Colon cancer test tissue array, with normal colon tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T051 |
Colon cancer test tissue array, with normal colon tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T052 Colon cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T052 |
Colon cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T053 Colon cancer test tissue array, with normal colon tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T053 |
Colon cancer test tissue array, with normal colon tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T054 Colon tumor test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T052 US Biomax 88 |
T054 |
Colon tumor test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T052 |
US Biomax |
|
88€ |
|
Pub |
T061 Rectal cancer test tissue array, with normal rectal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T061 |
Rectal cancer test tissue array, with normal rectal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T063 Rectum cancer test tissue array, with normal rectum tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T063 |
Rectum cancer test tissue array, with normal rectum tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T071 Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T071 |
Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T072 Kidney cancer test tissue array, with normal tissue, TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T072 |
Kidney cancer test tissue array, with normal tissue, TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T073 Kidney cancer test tissue array, with normal kidney tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T073 |
Kidney cancer test tissue array, with normal kidney tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T081 Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085 US Biomax 88 |
T081 |
Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T085 |
US Biomax |
|
88€ |
|
Pub |
T082 Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases 24 cores, replaced by T084 US Biomax 88 |
T082 |
Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases 24 cores, replaced by T084 |
US Biomax |
|
88€ |
|
Pub |
T083 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T083 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T085 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088 US Biomax 88 |
T085 |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by T088 |
US Biomax |
|
88€ |
|
Pub |
T086 Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084 US Biomax 88 |
T086 |
Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084 |
US Biomax |
|
88€ |
|
Pub |
T086a Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed US Biomax 90 |
T086a |
Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T086b Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed US Biomax 90 |
T086b |
Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T088 Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085 US Biomax 88 |
T088 |
Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085 |
US Biomax |
|
88€ |
|
Pub |
T091 Endometrial cancer test tissue array, with normal endometriual tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T091 |
Endometrial cancer test tissue array, with normal endometriual tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T092 Endometrium cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T092 |
Endometrium cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T093 Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T093 |
Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T101 Cervix cancer test tissue array, with normal cervix control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T101 |
Cervix cancer test tissue array, with normal cervix control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T102 Cervix cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T102 |
Cervix cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T111 Ovary cancer test tissue array, with normal ovary control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T111 |
Ovary cancer test tissue array, with normal ovary control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T112 Ovary cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T112 |
Ovary cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T113 Ovarian cancer test tissue array, with normal ovary tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T113 |
Ovarian cancer test tissue array, with normal ovary tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T121 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T121 |
Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T122 Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T122 |
Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T123 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T123 |
Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T124 Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed US Biomax 90 |
T124 |
Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T141 Pancreatic cancer test tissue array, with normal pancreas control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T141 |
Pancreatic cancer test tissue array, with normal pancreas control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T142 Pancreatic cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T142 |
Pancreatic cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T143 Pancreatic cancer test tissue array, with normal pancreatic tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T143 |
Pancreatic cancer test tissue array, with normal pancreatic tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T151 Thyroid cancer test tissue array, with normal thyroid control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T151 |
Thyroid cancer test tissue array, with normal thyroid control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T153 Thyroid cancer test tissue array, with normal thyroid gland tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T153 |
Thyroid cancer test tissue array, with normal thyroid gland tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T163 Nose, pharyngeal and laryngeal cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T163 |
Nose, pharyngeal and laryngeal cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T172 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T172 |
Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T173 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T173 |
Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T173a Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed US Biomax 90 |
T173a |
Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T174 Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores, replacing T171 US Biomax 88 |
T174 |
Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores, replacing T171 |
US Biomax |
|
88€ |
|
Pub |
T174a Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed US Biomax 90 |
T174a |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T175 Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed US Biomax 105 |
T175 |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
T191 Prostate cancer test tissue array, with normal prostate control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T191 |
Prostate cancer test tissue array, with normal prostate control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T192 Prostate cancer test tissue array, with normal control tissue, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 12 cases 24 cores, replaced by T195 US Biomax 88 |
T192 |
Prostate cancer test tissue array, with normal control tissue, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 12 cases 24 cores, replaced by T195 |
US Biomax |
|
88€ |
|
Pub |
T193 Prostate cancer test tissue array, with normal prostate tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T193 |
Prostate cancer test tissue array, with normal prostate tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T195a Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed US Biomax 105 |
T195a |
Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
T211 Skin cancer test tissue array, with normal skin control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T211 |
Skin cancer test tissue array, with normal skin control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T212 Skin cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T212 |
Skin cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T221 Penis cancer test tissue array, with normal penis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T221 |
Penis cancer test tissue array, with normal penis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T223 Penis cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T223 |
Penis cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T231 Testis cancer test tissue array, with normal testis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T231 |
Testis cancer test tissue array, with normal testis control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T231a Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed US Biomax 90 |
T231a |
Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T241 Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T241 |
Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T261 Bone and cartilage cancer test tissue array, with normal bone and cartilage tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T261 |
Bone and cartilage cancer test tissue array, with normal bone and cartilage tissue as control, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T271 Oral cavity tumor test tissue array, with normal oral cavity control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T271 |
Oral cavity tumor test tissue array, with normal oral cavity control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T273 Oral cavity cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores US Biomax 88 |
T273 |
Oral cavity cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T301 Heart tumor test tissue array, with normal heart tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T301 |
Heart tumor test tissue array, with normal heart tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T321 Spleen tumor test tissue array, with normal spleen control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T321 |
Spleen tumor test tissue array, with normal spleen control tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T342 Head & Neck cancer test tissue array, with normal tongue and epiglottis control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores US Biomax 88 |
T342 |
Head & Neck cancer test tissue array, with normal tongue and epiglottis control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T386 Malignant melanoma test tissue array, with normal skin tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T385 US Biomax 88 |
T386 |
Malignant melanoma test tissue array, with normal skin tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T385 |
US Biomax |
|
88€ |
|
Pub |
T392 Mesothelioma test tissue array, with normal mesothelial control tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T391 US Biomax 88 |
T392 |
Mesothelioma test tissue array, with normal mesothelial control tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T391 |
US Biomax |
|
88€ |
|
Pub |
T421 Small intestine cancer test tissue array, with normal small intestine tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T421 |
Small intestine cancer test tissue array, with normal small intestine tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
T461 Thymus cancer test tissue array, with normal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores US Biomax 88 |
T461 |
Thymus cancer test tissue array, with normal control tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores |
US Biomax |
|
88€ |
|
Pub |
TE242 Testis cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing TE241 US Biomax 88 |
TE242 |
Testis cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing TE241 |
US Biomax |
|
88€ |
|
Pub |
TH481 Thyroid cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with grade and stage info US Biomax 160 |
TH481 |
Thyroid cancer tissue array with unmatched normal adjacent tissues, 48 cases 48 cores, with grade and stage info |
US Biomax |
|
160€ |
|
Pub |
TH8010 Thyroid cancer and normal tissue array, with stage and grade info, 80 cases 80 cores US Biomax 266 |
TH8010 |
Thyroid cancer and normal tissue array, with stage and grade info, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
TH806 Thyroid medullary cancer tissue array and normal tissues, 40 cases 80 cores, with grade and stage data US Biomax 266 |
TH806 |
Thyroid medullary cancer tissue array and normal tissues, 40 cases 80 cores, with grade and stage data |
US Biomax |
|
266€ |
|
Pub |
TH808 Thyroid cancer and normal tissue array, with grade and stage data, 40 cases 80 cores US Biomax 266 |
TH808 |
Thyroid cancer and normal tissue array, with grade and stage data, 40 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
TH809a Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed US Biomax 296 |
TH809a |
Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BC001113 Esophageal adenocarcinoma, cardia adenocarcinoma, normal esophageal and cardia tissue array, 50 cases 50 cores (previously cat ES501) US Biomax 189 |
BC001113 |
Esophageal adenocarcinoma, cardia adenocarcinoma, normal esophageal and cardia tissue array, 50 cases 50 cores (previously cat ES501) |
US Biomax |
|
189€ |
|
Pub |
BC01001 Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases 18 cores US Biomax 231 |
BC01001 |
Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases 18 cores |
US Biomax |
|
231€ |
|
Pub |
BC01011 Stomach carcinoma (multi tissue combined panel) tissue array, 24 cases 72 cores, replaced by ST721 US Biomax 160 |
BC01011 |
Stomach carcinoma (multi tissue combined panel) tissue array, 24 cases 72 cores, replaced by ST721 |
US Biomax |
|
160€ |
|
Pub |
BC01014 Stomach carcinoma tissue array (multi tissue combined panel), 71 cases 72 cores, replaced by ST807 US Biomax 231 |
BC01014 |
Stomach carcinoma tissue array (multi tissue combined panel), 71 cases 72 cores, replaced by ST807 |
US Biomax |
|
231€ |
|
Pub |
BC02011 Multiple esophageal cancer tissue array, 69 cases 72 cores US Biomax 160 |
BC02011 |
Multiple esophageal cancer tissue array, 69 cases 72 cores |
US Biomax |
|
160€ |
|
Pub |
BC02111 Esophagus adenocarcinoma and normal tissue array, 23 cases 80 cores US Biomax 189 |
BC02111 |
Esophagus adenocarcinoma and normal tissue array, 23 cases 80 cores |
US Biomax |
|
189€ |
|
Pub |
BC03002 Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores US Biomax 266 |
BC03002 |
Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
BC03021 Liver carcinoma (combination of adjacent and normal) tissue array, 42 cases 63 cores, replaced by LV803 US Biomax 231 |
BC03021 |
Liver carcinoma (combination of adjacent and normal) tissue array, 42 cases 63 cores, replaced by LV803 |
US Biomax |
|
231€ |
|
Pub |
BC04002 Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 cores US Biomax 266 |
BC04002 |
Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BC04011 Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed US Biomax 185 |
BC04011 |
Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed |
US Biomax |
|
185€ |
|
Pub |
BC04012 Lung carcinoma (multi tissue combined panel) tissue array, 68 cases 72 cores US Biomax 160 |
BC04012 |
Lung carcinoma (multi tissue combined panel) tissue array, 68 cases 72 cores |
US Biomax |
|
160€ |
|
Pub |
BC04014 Non small cell lung carcinoma (NSCLC) tissue array, 63 cases 63 cores, replaced by LC807 US Biomax 160 |
BC04014 |
Non small cell lung carcinoma (NSCLC) tissue array, 63 cases 63 cores, replaced by LC807 |
US Biomax |
|
160€ |
|
Pub |
BC04015 Lung carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores US Biomax 160 |
BC04015 |
Lung carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores |
US Biomax |
|
160€ |
|
Pub |
BC04016 Lung carcinoma tissue array, 72 cases 72 cores, replaced by LC726 US Biomax 160 |
BC04016 |
Lung carcinoma tissue array, 72 cases 72 cores, replaced by LC726 |
US Biomax |
|
160€ |
|
Pub |
BC04021 Lung carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores US Biomax 160 |
BC04021 |
Lung carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores |
US Biomax |
|
160€ |
|
Pub |
BC05002 Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores US Biomax 266 |
BC05002 |
Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
BC05011 Multiple types of colon carcinoma tissue array, 72 cases 72 cores, replaced by CO804 US Biomax 231 |
BC05011 |
Multiple types of colon carcinoma tissue array, 72 cases 72 cores, replaced by CO804 |
US Biomax |
|
231€ |
|
Pub |
BC050112 Colon metastatic carcinoma tissue array, 23 cases 63 cores, replaced by CO726 US Biomax 231 |
BC050112 |
Colon metastatic carcinoma tissue array, 23 cases 63 cores, replaced by CO726 |
US Biomax |
|
231€ |
|
Pub |
BC05012 Colon carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores. US Biomax 231 |
BC05012 |
Colon carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores. |
US Biomax |
|
231€ |
|
Pub |
BC06002 Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases 72 cores US Biomax 321 |
BC06002 |
Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases 72 cores |
US Biomax |
|
321€ |
|
Pub |
BC06011 Rectum carcinoma (multi tissue combined panel) tissue array, 71 cases 72 cores US Biomax 160 |
BC06011 |
Rectum carcinoma (multi tissue combined panel) tissue array, 71 cases 72 cores |
US Biomax |
|
160€ |
|
Pub |
BC06022 Rectum carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by RE722 US Biomax 160 |
BC06022 |
Rectum carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores, replaced by RE722 |
US Biomax |
|
160€ |
|
Pub |
BC07011 Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replaced by BC07013 US Biomax 160 |
BC07011 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replaced by BC07013 |
US Biomax |
|
160€ |
|
Pub |
BC07012 Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores, replaced by BC07015 US Biomax 160 |
BC07012 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores, replaced by BC07015 |
US Biomax |
|
160€ |
|
Pub |
BC07014 Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores US Biomax 160 |
BC07014 |
Kidney carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores |
US Biomax |
|
160€ |
|
Pub |
BC08023 Breast carcinoma (combination of adjacent and normal) tissue array, 57 cases 63 cores US Biomax 231 |
BC08023 |
Breast carcinoma (combination of adjacent and normal) tissue array, 57 cases 63 cores |
US Biomax |
|
231€ |
|
Pub |
BC08032 Infiltrating duct carcinoma (combination of adjacent and normal) tissue array, 57 cases 63 cores US Biomax 231 |
BC08032 |
Infiltrating duct carcinoma (combination of adjacent and normal) tissue array, 57 cases 63 cores |
US Biomax |
|
231€ |
|
Pub |
BC081115 Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120 US Biomax 278 |
BC081115 |
Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores, replaced by BC081120 |
US Biomax |
|
278€ |
|
Pub |
BC081116 Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores US Biomax 278 |
BC081116 |
Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases 110 cores |
US Biomax |
|
278€ |
|
Pub |
BC08118 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases 100 cores US Biomax 321 |
BC08118 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases 100 cores |
US Biomax |
|
321€ |
|
Pub |
BC11011 Ovarian carcinoma (multi tissue combined panel) tissue array (replaced by OV802), 70 cases 72 cores US Biomax 160 |
BC11011 |
Ovarian carcinoma (multi tissue combined panel) tissue array (replaced by OV802), 70 cases 72 cores |
US Biomax |
|
160€ |
|
Pub |
BC11012 Ovarian carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores US Biomax 160 |
BC11012 |
Ovarian carcinoma (multi tissue combined panel) tissue array, 70 cases 72 cores |
US Biomax |
|
160€ |
|
Pub |
BC111109 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores US Biomax 231 |
BC111109 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores |
US Biomax |
|
231€ |
|
Pub |
BC111110 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores US Biomax 231 |
BC111110 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases 70 cores |
US Biomax |
|
231€ |
|
Pub |
BC11115 Ovary serous papillary adenocarcinoma, lymph node metastasis with adjacent normal ovary tissue array, including TNM and pathology grade, 100 cases 100 cores US Biomax 321 |
BC11115 |
Ovary serous papillary adenocarcinoma, lymph node metastasis with adjacent normal ovary tissue array, including TNM and pathology grade, 100 cases 100 cores |
US Biomax |
|
321€ |
|
Pub |
BC15012 Thyroid carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores US Biomax 231 |
BC15012 |
Thyroid carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores |
US Biomax |
|
231€ |
|
Pub |
BC30013 Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores US Biomax 231 |
BC30013 |
Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores |
US Biomax |
|
231€ |
|
Pub |
BCN721 Multiple cancer (12 common types) tissue array with unmatched normal adjacent tissue, 71 cases 72 cores US Biomax 231 |
BCN721 |
Multiple cancer (12 common types) tissue array with unmatched normal adjacent tissue, 71 cases 72 cores |
US Biomax |
|
231€ |
|
Pub |
BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
BL1001 |
Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BL1002 Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases 100 cores US Biomax 266 |
BL1002 |
Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
BL1501 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BL1921 Mid advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
BL1921 |
Mid advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
BL208 Tissue microarray of bladder cancer and normal tissue, high density (69 cases 208 cores) with grade and stage data US Biomax 456 |
BL208 |
Tissue microarray of bladder cancer and normal tissue, high density (69 cases 208 cores) with grade and stage data |
US Biomax |
|
456€ |
|
Pub |
BL242 Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores US Biomax 189 |
BL242 |
Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
BL244 Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 |
BL244 |
Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
BL802 Bladder cancer tissue array with normal tissue, 80 cases 80 cores, replacing BC12012 US Biomax 266 |
BL802 |
Bladder cancer tissue array with normal tissue, 80 cases 80 cores, replacing BC12012 |
US Biomax |
|
266€ |
|
Pub |
BL803 Bladder cancer and normal tissue array with TNM and grade data, 40 cases 80 cores US Biomax 266 |
BL803 |
Bladder cancer and normal tissue array with TNM and grade data, 40 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
BL805 Mid advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores US Biomax 266 |
BL805 |
Mid advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases 80 cores |
US Biomax |
|
266€ |
|
Pub |
BN00119 Multiple organ normal tissue array, 40 cases 40 cores, replacing BN00112 US Biomax 266 |
BN00119 |
Multiple organ normal tissue array, 40 cases 40 cores, replacing BN00112 |
US Biomax |
|
266€ |
|
Pub |
BN01013 Normal stomach tissue (multi sites) array, 70 cases 72 cores US Biomax 160 |
BN01013 |
Normal stomach tissue (multi sites) array, 70 cases 72 cores |
US Biomax |
|
160€ |
|
Pub |
BN05011 Normal colon tissue (multi site) array, 23 cases 63 cores, replaced by BN05014 US Biomax 160 |
BN05011 |
Normal colon tissue (multi site) array, 23 cases 63 cores, replaced by BN05014 |
US Biomax |
|
160€ |
|
Pub |
BN06011 Normal rectum tissue (multi sites) tissue array, 23 cases 63 cores US Biomax 160 |
BN06011 |
Normal rectum tissue (multi sites) tissue array, 23 cases 63 cores |
US Biomax |
|
160€ |
|
Pub |
BN06012 Normal rectum tissue (multi sites) tissue array, 70 cases 72 cores US Biomax 160 |
BN06012 |
Normal rectum tissue (multi sites) tissue array, 70 cases 72 cores |
US Biomax |
|
160€ |
|
Pub |
BN07012 Normal kidney tissue (multi sites) tissue array, 70 cases 72 cores, replaced by KD803 US Biomax 160 |
BN07012 |
Normal kidney tissue (multi sites) tissue array, 70 cases 72 cores, replaced by KD803 |
US Biomax |
|
160€ |
|
Pub |
BN08013 Normal breast tissue (multi sites) array, 71 cases 72 cores, replaced by BRN801 US Biomax 160 |
BN08013 |
Normal breast tissue (multi sites) array, 71 cases 72 cores, replaced by BRN801 |
US Biomax |
|
160€ |
|
Pub |
BN1002 Multiple organ (20) normal tissue array, 100 cases 100 cores, replacing BN1001 US Biomax 266 |
BN1002 |
Multiple organ (20) normal tissue array, 100 cases 100 cores, replacing BN1001 |
US Biomax |
|
266€ |
|
Pub |
BN1002a Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed US Biomax 296 |
BN1002a |
Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BN126 Multiple organ normal tissue array, replacing BN113, 45 cases 45 cores US Biomax 231 |
BN126 |
Multiple organ normal tissue array, replacing BN113, 45 cases 45 cores |
US Biomax |
|
231€ |
|
Pub |
BN129 Multiple organ adjacent normal tissue array, 48 cases 48 cores, replacing BN116 US Biomax 160 |
BN129 |
Multiple organ adjacent normal tissue array, 48 cases 48 cores, replacing BN116 |
US Biomax |
|
160€ |
|
Pub |
BN243 Multiple normal (12 type) tissue array, 12 cases 24 cores, replacing BN241 US Biomax 88 |
BN243 |
Multiple normal (12 type) tissue array, 12 cases 24 cores, replacing BN241 |
US Biomax |
|
88€ |
|
Pub |
BN243a Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed US Biomax 105 |
BN243a |
Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
BN501 Normal human top 10 organ tissue array, 50 cases 50 cores, replacing BN00012 and BN00013 US Biomax 160 |
BN501 |
Normal human top 10 organ tissue array, 50 cases 50 cores, replacing BN00012 and BN00013 |
US Biomax |
|
160€ |
|
Pub |
BN961 Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases 102 cores, replacing BN861 US Biomax 266 |
BN961 |
Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases 102 cores, replacing BN861 |
US Biomax |
|
266€ |
|
Pub |
BO244 Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replacing BO243 US Biomax 100 |
BO244 |
Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replacing BO243 |
US Biomax |
|
100€ |
|
Pub |
BO244a Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 |
BO244a |
Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
BR01015 Multiple organ, normal tissue array, 8 normal tissues, 160 cases 160 cores, replacing BR01011 US Biomax 278 |
BR01015 |
Multiple organ, normal tissue array, 8 normal tissues, 160 cases 160 cores, replacing BR01011 |
US Biomax |
|
278€ |
|
Pub |
BR1002 Tissue microarray of breast cancer and normal tissue, 97 cases 100 cores, with stage and grade information US Biomax 266 |
BR1002 |
Tissue microarray of breast cancer and normal tissue, 97 cases 100 cores, with stage and grade information |
US Biomax |
|
266€ |
|
Pub |
BR1003 Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data US Biomax 266 |
BR1003 |
Breast pre cancerous disease and cancer tissue array (100 cases 101 cores), with clinical stage and pathology grade data |
US Biomax |
|
266€ |
|
Pub |
BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
BR1007 |
Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BR1503 Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502 US Biomax 278 |
BR1503 |
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502 |
US Biomax |
|
278€ |
|
Pub |
BR1504 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores US Biomax 266 |
BR1504 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores |
US Biomax |
|
266€ |
|
Pub |
BR1505 Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin US Biomax 296 |
BR1505 |
Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin |
US Biomax |
|
296€ |
|
Pub |
BR1921 High density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases 192 cores US Biomax 456 |
BR1921 |
High density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grading and staging data,192 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
BR1922 Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores US Biomax 456 |
BR1922 |
Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores |
US Biomax |
|
456€ |
|
Pub |
BR208 High density, multiple breast cancer (1 3 grade) and normal breast tissue array, 70 cases 208 cores US Biomax 456 |
BR208 |
High density, multiple breast cancer (1 3 grade) and normal breast tissue array, 70 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20810 Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20810 |
Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20811 Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20811 |
Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20812 Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20812 |
Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20813 Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20813 |
Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20814 Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20814 |
Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |
BR20815 Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores US Biomax 456 |
BR20815 |
Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores |
US Biomax |
|
456€ |
|
Pub |